Ieq Capital LLC Has $2.10 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Ieq Capital LLC grew its stake in Agilent Technologies, Inc. (NYSE:A) by 8.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,224 shares of the medical research company’s stock after purchasing an additional 1,300 shares during the period. Ieq Capital LLC’s holdings in Agilent Technologies were worth $2,103,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Crewe Advisors LLC raised its stake in shares of Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory bought a new position in shares of Agilent Technologies during the 4th quarter worth about $26,000. Ridgewood Investments LLC acquired a new stake in shares of Agilent Technologies during the 2nd quarter valued at about $29,000. Rise Advisors LLC increased its stake in Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. acquired a new position in Agilent Technologies in the first quarter worth about $34,000. Institutional investors own 87.42% of the company’s stock.

Wall Street Analysts Forecast Growth

A has been the topic of a number of recent research reports. Bank of America lifted their price objective on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Wolfe Research cut Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. Evercore ISI upped their target price on shares of Agilent Technologies from $130.00 to $135.00 and gave the stock an “in-line” rating in a report on Thursday, August 22nd. Stifel Nicolaus reissued a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a report on Monday, August 26th. Finally, Robert W. Baird cut their price target on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a report on Thursday, May 30th. One analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $141.60.

Agilent Technologies Trading Down 1.3 %

Shares of NYSE A opened at $140.09 on Friday. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35. The company has a market cap of $40.87 billion, a PE ratio of 33.12, a P/E/G ratio of 6.43 and a beta of 1.05. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The company has a 50-day moving average of $137.87 and a two-hundred day moving average of $139.21.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm posted $1.43 earnings per share. The company’s revenue was down 5.6% on a year-over-year basis. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be paid a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Insider Buying and Selling

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at $3,497,110. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is currently owned by insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.